DD200469A5 - Verfahren zur herstellung von als histamin-h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten - Google Patents

Verfahren zur herstellung von als histamin-h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten Download PDF

Info

Publication number
DD200469A5
DD200469A5 DD81233796A DD23379681A DD200469A5 DD 200469 A5 DD200469 A5 DD 200469A5 DD 81233796 A DD81233796 A DD 81233796A DD 23379681 A DD23379681 A DD 23379681A DD 200469 A5 DD200469 A5 DD 200469A5
Authority
DD
German Democratic Republic
Prior art keywords
group
pyridyl
general formula
substituted
pyrimidone
Prior art date
Application number
DD81233796A
Other languages
German (de)
English (en)
Inventor
David G Cooper
George S Sach
Original Assignee
David G Cooper
George S Sach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David G Cooper, George S Sach filed Critical David G Cooper
Publication of DD200469A5 publication Critical patent/DD200469A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
DD81233796A 1980-10-01 1981-10-01 Verfahren zur herstellung von als histamin-h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten DD200469A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031685 1980-10-01

Publications (1)

Publication Number Publication Date
DD200469A5 true DD200469A5 (de) 1983-05-04

Family

ID=10516418

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81233796A DD200469A5 (de) 1980-10-01 1981-10-01 Verfahren zur herstellung von als histamin-h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten

Country Status (22)

Country Link
US (1) US4385058A (ko)
EP (1) EP0049173B1 (ko)
JP (1) JPS5791986A (ko)
KR (1) KR830007630A (ko)
AT (1) ATA420581A (ko)
AU (1) AU547215B2 (ko)
CA (1) CA1170261A (ko)
DD (1) DD200469A5 (ko)
DE (1) DE3171234D1 (ko)
DK (1) DK435681A (ko)
ES (1) ES8301966A1 (ko)
FI (1) FI813054L (ko)
GR (1) GR75783B (ko)
IL (1) IL63913A0 (ko)
NO (1) NO813326L (ko)
PH (2) PH17948A (ko)
PL (1) PL233256A1 (ko)
PT (1) PT73691B (ko)
RO (1) RO82214A (ko)
YU (1) YU236881A (ko)
ZA (1) ZA816794B (ko)
ZW (1) ZW21281A1 (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA823149B (en) * 1981-05-27 1983-03-30 Smithkline Beckman Corp Chemical process
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
EP0089153B1 (en) * 1982-03-17 1986-09-24 Smith Kline & French Laboratories Limited Pyridine derivatives
DE3365869D1 (en) * 1982-07-30 1986-10-09 Smith Kline French Lab Amino pyrimidinones and their preparation
PT77287B (en) * 1982-10-01 1986-02-04 Smith Kline French Lab Compound
AU1956283A (en) * 1982-10-02 1984-04-05 Smith Kline & French Laboratories Limited 1-(3-(4-(substited aminomethyl)pyrid-2-yl-oxy)-prop-1-yl- amino) - 2-aminocyclobut-i-ene-3,4-diones
PT77623B (en) * 1982-11-25 1986-03-19 Smith Kline French Lab Process for the preparation of a small class of histamine h2-antagonists
JO1274B1 (en) * 1982-12-03 1985-04-20 سيدني ساخ جورج Pyridine derivatives
DE3374313D1 (de) * 1982-12-23 1987-12-10 Smith Kline French Lab Aminopyrimidinone derivatives as histamine h1-antagonists
DK584683A (da) * 1982-12-23 1984-06-24 Smith Kline French Lab Pyridinderivater
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
GB8319874D0 (en) * 1983-07-23 1983-08-24 Smith Kline French Lab Compounds
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
GB8601816D0 (en) * 1986-01-25 1986-02-26 Smith Kline French Lab Pyridine derivatives
US4931452A (en) * 1987-11-10 1990-06-05 The Dow Chemical Company N-cyanomethyl-2-pyridinone insecticides
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4218452A (en) * 1975-10-02 1980-08-19 Smith Kline & French Laboratories Limited Substituted 4-pyrimidone compounds, compositions and methods of use
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
IN146736B (ko) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
IN151188B (ko) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4227000A (en) * 1978-04-11 1980-10-07 Smith Kline & French Laboratories Limited Intermediates in the process for making histamine antagonists
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
US4255428A (en) * 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives

Also Published As

Publication number Publication date
RO82214A (ro) 1983-07-07
JPS6328069B2 (ko) 1988-06-07
KR830007630A (ko) 1983-11-04
RO82214B (ro) 1983-06-30
ES505898A0 (es) 1983-01-01
EP0049173B1 (en) 1985-07-03
ZW21281A1 (en) 1981-11-18
PH17950A (en) 1985-02-11
ES8301966A1 (es) 1983-01-01
US4385058A (en) 1983-05-24
AU7595181A (en) 1982-04-08
AU547215B2 (en) 1985-10-10
PH17948A (en) 1985-02-11
ATA420581A (de) 1985-03-15
PT73691A (en) 1981-10-01
IL63913A0 (en) 1981-12-31
GR75783B (ko) 1984-08-02
EP0049173A2 (en) 1982-04-07
EP0049173A3 (en) 1982-06-30
DK435681A (da) 1982-04-02
ZA816794B (en) 1982-10-27
JPS5791986A (en) 1982-06-08
YU236881A (en) 1984-02-29
PL233256A1 (ko) 1982-11-08
CA1170261A (en) 1984-07-03
DE3171234D1 (en) 1985-08-08
NO813326L (no) 1982-04-02
FI813054L (fi) 1982-04-02
PT73691B (en) 1982-12-10

Similar Documents

Publication Publication Date Title
DD200469A5 (de) Verfahren zur herstellung von als histamin-h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
EP0877744B1 (de) Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung
DE897405C (de) Verfahren zur Herstellung substituierter Piperazine
EP0427765B1 (de) Alkoxy-4(1h)-pyridon-derivative, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69232099T2 (de) 1,3-substituierte cycloalkene und cycloalkane mit zentraler nervensystemwirkung
DE69212870T2 (de) 4-Aryl-thiazole oder imidazolederivate
DE4425146A1 (de) Verwendung heterocyclischer Verbindungen
DD233374A5 (de) Verfahren zur herstellung von 2-(n-subst.-guanidino)-4-heteroarylthiazole
DD142052A5 (de) Verfahren zur herstellung von pyrimidonen
HU196990B (en) Process for producing piperazine derivatives with antiarrhythmic effect and pharmaceuticals comprising same
NO170883B (no) Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
DE2157424A1 (de) N,n'-disubstituierte cyclische diamine und verfahren zu deren herstellung
DE3874358T2 (de) 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
DE2658267A1 (de) Pyrimid-4-on- und -thion-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH642952A5 (de) Pyrimidonderivate.
DE69222459T2 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
DE10133665A1 (de) Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
DE3889987T2 (de) N-[(2-Oxopyrrolidin-1-yl)acetyl]piperazin-Derivate und Arzneimittel gegen senile Dementia.
DD149217A5 (de) Verfahren zur herstellung von pyrimidonderivaten
DD202291A5 (de) Verfahren zur herstellung von als histamin-h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2604056A1 (de) Thiocarbaminsaeure-derivate
US4388317A (en) Pyrimidones having histamine H2 -antagonist activity
JPH04225975A (ja) N−[3−(1h−イミダゾール−1−イル)フエニル]−4−(置換)−2−ピリミジナミン合成の改良法
DD144916A5 (de) Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen
DD206994A5 (de) Verfahren zur herstellung von pyridinderivaten

Legal Events

Date Code Title Description
A5 Published as prov. exclusive patent